Renal apolipoprotein A-I amyloidosis associated with a novel mutant Leu64Pro

Charles L. Murphy, Shuching Wang, Kristal Weaver, Morie A. Gertz, Deborah T. Weiss, Alan Solomon

Research output: Contribution to journalArticlepeer-review

29 Scopus citations


Apolipoprotein A-I amyloidosis (Apo A-I) is an inherited systemic disease that results from the pathologic deposition in tissues throughout the body of fibrils composed of Apo A-I-related molecules. This disorder has been linked to mutations occurring within the coding region of the Apo A-I gene and, to date, 11 such substitutions have been documented. In 4 of these cases, the kidney was the target organ of the disease process. The authors report their studies on a patient with renal amyloidosis and a heretofore undescribed alteration in the amyloidogenic precursor protein. Analyses of genomic DNA evidenced a transition in the second base of codon 64 (T→C) in one Apo A-I allele that resulted in the replacement of leucine by proline at position 64 (Leu64Pro). Additionally, fibrils extracted from the kidney and characterized chemically were found to be composed almost exclusively of an approximately 96-residue N-terminal Apo A-I fragment that contained the Leu64Pro substitution. These studies have provided further evidence for Apo A-I amyloidogenicity and the propensity of certain mutants to deposit in renal parenchyma.

Original languageEnglish (US)
Pages (from-to)1103-1109
Number of pages7
JournalAmerican Journal of Kidney Diseases
Issue number6
StatePublished - Dec 2004


  • Amyloidosis
  • apolipoprotein A-I
  • renal pathology

ASJC Scopus subject areas

  • Nephrology


Dive into the research topics of 'Renal apolipoprotein A-I amyloidosis associated with a novel mutant Leu64Pro'. Together they form a unique fingerprint.

Cite this